Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana-Reference-Cited by-同舟云学术

Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana

Published:2018-08 Issue:8 Volume:34 Page:667-671
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Diphoko Thabo¹²,Gaseitsiwe Simani¹³,Kasvosve Ishmael²,Moyo Sikhulile¹³,Okatch Harriet⁴,Musonda Rosemary¹³,Wainberg Mark⁵,Makhema Joseph¹³,Marlink Richard⁶,Novitsky Vladimir¹³,Essex Max¹³

Affiliation:

1. Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.

2. Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana.

3. Harvard T.H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, Massachusetts.

4. Centre for Public Health Initiatives, University of Pennsylvania, Philadelphia, Pennsylvania.

5. Lady Davis Institute for Medical Research, McGill University, Montreal, Canada.

6. Rutgers Global Health Institute, Rutgers Biomedical and Health Sciences, Rutgers University, New Brunswick, New Jersey.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2017.0135

Reference30 articles.

1. Class-Sparing Regimens for Initial Treatment of HIV-1 Infection

2. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

3. Antiviral Briefs

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges for Novel Antiretroviral Development in an Era of Widespread tenofovir-disoproxil/lamivudine (or emtricitabine)/dolutegravir availability (TLD) Availability;Clinical Infectious Diseases;2024-07-11

2. Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use;Journal of Antimicrobial Chemotherapy;2023-08-16

3. Current ARTs, Virologic Failure, and Implications for AIDS Management: A Systematic Review;Viruses;2023-08-13

4. Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk Reduction;Clinical Infectious Diseases;2022-11-08

5. Use of long-acting injectable antiretroviral agents for human immunodeficiency Virus: A review;Journal of Clinical Virology;2022-01